Peter Couroux

760 total citations
21 papers, 510 citations indexed

About

Peter Couroux is a scholar working on Immunology and Allergy, Physiology and Dermatology. According to data from OpenAlex, Peter Couroux has authored 21 papers receiving a total of 510 indexed citations (citations by other indexed papers that have themselves been cited), including 17 papers in Immunology and Allergy, 10 papers in Physiology and 5 papers in Dermatology. Recurrent topics in Peter Couroux's work include Allergic Rhinitis and Sensitization (17 papers), Asthma and respiratory diseases (10 papers) and Food Allergy and Anaphylaxis Research (8 papers). Peter Couroux is often cited by papers focused on Allergic Rhinitis and Sensitization (17 papers), Asthma and respiratory diseases (10 papers) and Food Allergy and Anaphylaxis Research (8 papers). Peter Couroux collaborates with scholars based in Canada, United States and Denmark. Peter Couroux's co-authors include Mark Larché, Roderick P. Hafner, Anne Marie Salapatek, Deepen Patel, Pascal Hickey, Paul Laidler, Michael J. Alexander, Peter S. Creticos, Deborah A. Gentile and Robert E. Esch and has published in prestigious journals such as Journal of Allergy and Clinical Immunology, Allergy and American Journal of Clinical Pathology.

In The Last Decade

Peter Couroux

20 papers receiving 479 citations

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name h Career Trend Papers Cites
Peter Couroux Canada 10 444 376 169 50 22 21 510
P.S. Norman United States 5 368 0.8× 295 0.8× 121 0.7× 38 0.8× 11 0.5× 15 441
Sylvie Galvain France 9 891 2.0× 724 1.9× 476 2.8× 115 2.3× 30 1.4× 11 911
A.P. Khattignavong United States 5 440 1.0× 423 1.1× 197 1.2× 72 1.4× 18 0.8× 5 608
Stephanie Hofmaier Germany 10 329 0.7× 275 0.7× 88 0.5× 51 1.0× 3 0.1× 12 409
Nili Wei China 11 205 0.5× 153 0.4× 81 0.5× 37 0.7× 6 0.3× 19 263
N. N. Bahceciler Türkiye 4 333 0.8× 310 0.8× 185 1.1× 52 1.0× 12 0.5× 5 375
Kraft Austria 7 525 1.2× 257 0.7× 226 1.3× 12 0.2× 5 0.2× 7 579
Paolo Bonazza Italy 4 427 1.0× 359 1.0× 228 1.3× 86 1.7× 19 0.9× 6 461
Alessandra Zaffiro Italy 9 322 0.7× 95 0.3× 223 1.3× 32 0.6× 5 0.2× 15 485
H.‐J. Mailing Denmark 6 505 1.1× 393 1.0× 310 1.8× 70 1.4× 16 0.7× 8 549

Countries citing papers authored by Peter Couroux

Since Specialization
Citations

This map shows the geographic impact of Peter Couroux's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Peter Couroux with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Peter Couroux more than expected).

Fields of papers citing papers by Peter Couroux

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Peter Couroux. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Peter Couroux. The network helps show where Peter Couroux may publish in the future.

Co-authorship network of co-authors of Peter Couroux

This figure shows the co-authorship network connecting the top 25 collaborators of Peter Couroux. A scholar is included among the top collaborators of Peter Couroux based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Peter Couroux. Peter Couroux is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

20 of 20 papers shown
1.
Couroux, Peter, et al.. (2022). A randomized, placebo‐controlled study to evaluate safety and pharmacokinetics of inhaled ribavirin. Clinical and Translational Science. 15(9). 2159–2171. 4 indexed citations
2.
Biedermann, Tilo, Peter Couroux, Tina Maria Greve, & Mika J. Mäkelä. (2021). Safety of the standardized quality tree sublingual immunotherapy tablet: Pooled safety analysis of clinical trials. Allergy. 76(12). 3733–3742. 6 indexed citations
3.
Couroux, Peter, Paulina Farías, Leena Rizvi, et al.. (2019). First clinical trials of novel ENaC targeting therapy, SPX-101, in healthy volunteers and adults with cystic fibrosis. Pulmonary Pharmacology & Therapeutics. 58. 101819–101819. 15 indexed citations
4.
Kim, Edwin, Scott H. Sicherer, Robert A. Wood, et al.. (2019). Development Of A Subcutaneous Immunotherapy (SCIT) With A Modified Peanut Extract Formulation For The Treatment Of Peanut Allergy. Journal of Allergy and Clinical Immunology. 143(2). AB243–AB243. 2 indexed citations
5.
Bousquet, Jean, Eli O. Meltzer, Peter Couroux, et al.. (2018). Onset of Action of the Fixed Combination Intranasal Azelastine-Fluticasone Propionate in an Allergen Exposure Chamber. The Journal of Allergy and Clinical Immunology In Practice. 6(5). 1726–1732.e6. 40 indexed citations
6.
7.
Sadoway, Tara, et al.. (2016). Field Scores of Allergic Individuals Correlate Positively with Self-Reported Outdoor Exposure Collected Using an Electronic Patient Data Acquisition Tablet (ePDAT™). Journal of Allergy and Clinical Immunology. 137(2). AB123–AB123. 1 indexed citations
8.
Nelson, Victoria A., et al.. (2016). Skin Prick Testing Alone Is Not a Good Predictor of Allergy Symptom Severity in Grass Allergic Patients. Journal of Allergy and Clinical Immunology. 137(2). AB255–AB255.
9.
Couroux, Peter, et al.. (2015). Fel d 1‐derived synthetic peptide immuno‐regulatory epitopes show a long‐term treatment effect in cat allergic subjects. Clinical & Experimental Allergy. 45(5). 974–981. 85 indexed citations
10.
Nelson, Victoria A., Peter Couroux, Tara Sadoway, Piyush M. Patel, & Anne Marie Salapatek. (2015). Comorbidity of allergic rhinitis and asthma to birch allergen in an environmental exposure chamber. PA4020–PA4020. 1 indexed citations
11.
Couroux, Peter, et al.. (2014). Persistent Treatment Effect Achieved At One Year After Four Doses Of Der p Derived Synthetic Peptide Immuno-Regulatory Epitopes In An Exposure Chamber Model Of House Dust Mite Allergy. Journal of Allergy and Clinical Immunology. 133(2). AB289–AB289. 17 indexed citations
12.
Creticos, Peter S., et al.. (2013). Randomized, double-blind, placebo-controlled trial of standardized ragweed sublingual-liquid immunotherapy for allergic rhinoconjunctivitis. Journal of Allergy and Clinical Immunology. 133(3). 751–758. 80 indexed citations
13.
14.
Couroux, Peter, et al.. (2013). 1. Two Year Persistent Treatment Effect Achieved After 4 Doses of Cat-Peptide Antigen Desensitization (Cat-PAD) in an Environmental Exposure Chamber (EEC) Model of Cat Allergy. Journal of Allergy and Clinical Immunology. 131(2). AB147–AB147. 6 indexed citations
15.
16.
Hafner, Roderick P., Peter Couroux, A. Salapatek, et al.. (2013). Immunotherapy – 2080. Fel d 1 derived peptide antigen desensitization results in a persistent treatment effect on symptoms of cat allergy 1 year after 4 doses. World Allergy Organization Journal. 6. P162–P162. 4 indexed citations
17.
Patel, Deepen, Peter Couroux, Pascal Hickey, et al.. (2012). Fel d 1–derived peptide antigen desensitization shows a persistent treatment effect 1 year after the start of dosing: A randomized, placebo-controlled study. Journal of Allergy and Clinical Immunology. 131(1). 103–109.e7. 152 indexed citations
18.
Couroux, Peter, et al.. (2009). Onset of action of ciclesonide once daily in the treatment of seasonal allergic rhinitis. Annals of Allergy Asthma & Immunology. 102(1). 62–68. 12 indexed citations
19.
John, Michael, et al.. (1994). Epidemiology of Pseudomonas cepacia colonization among patients with cystic fibrosis. Pediatric Pulmonology. 18(2). 108–113. 11 indexed citations
20.
Couroux, Peter, et al.. (1993). Comparison of the E-Test and Reference Agar Dilution Method for Susceptibility of Gram-Negative Anaerobic Organisms. American Journal of Clinical Pathology. 100(3). 301–303. 9 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Breakdown of academic impact, for papers by P.S. Norman Breakdown of academic impact, for papers by Sylvie Galvain Breakdown of academic impact, for papers by A.P. Khattignavong Breakdown of academic impact, for papers by Stephanie Hofmaier Breakdown of academic impact, for papers by Nili Wei Breakdown of academic impact, for papers by N. N. Bahceciler Breakdown of academic impact, for papers by Kraft Breakdown of academic impact, for papers by Paolo Bonazza Breakdown of academic impact, for papers by Alessandra Zaffiro Breakdown of academic impact, for papers by H.‐J. Mailing
Rankless by CCL
2026